Ticker Details
Vanda Pharmaceuticals Inc. Vanda Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs.
IPO Date:	April 12, 2006
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$319.24M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.27 | 2.85%
Avg Daily Range (30 D):	$0.14 | 2.63%
Avg Daily Range (90 D):	$0.15 | 2.49%

Institutional Daily Volume
Avg Daily Volume:	.62M
Avg Daily Volume (30 D):	.81M
Avg Daily Volume (90 D):	.85M

Trade Size
Avg Trade Size (Sh.):	139
Avg Trade Size (Sh.) (30 D):	76
Avg Trade Size (Sh.) (90 D):	83

Institutional Trades
Total Institutional Trades:	3,276
Avg Institutional Trade:	$1.48M
Avg Institutional Trade (30 D):	$.84M
Avg Institutional Trade (90 D):	$.86M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.52M
Avg Closing Trade (30 D):	$.84M
Avg Closing Trade (90 D):	$.87M
Avg Closing Volume:	123.54K

News

Dec 31, 2025 @ 9:09 AM Stock Market Today: S&P 500, Dow Jones Futures Dow... Source: Vishaal Sanjay

Oct 27, 2025 @ 5:00 PM Gastroparesis Market Poised for Extraordinary Grow... Source: Delveinsight

Aug 1, 2025 @ 8:18 AM Vanda (VNDA) Q2 Revenue Rises 4% Source: Jesterai

Oct 9, 2024 @ 5:00 PM Schizophrenia Clinical Trial Pipeline Insights Fea... Source: Delveinsight

Jun 7, 2024 @ 10:02 AM Vanda (VNDA) Surges 24.2%: Is This an Indication o... Source: Zacks Equity Research

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-4.63	$-1.04	$-.82
Diluted EPS	$-4.63	$-1.04	$-.82
Revenue	$215.72M	$50.53M	$51.72M
Gross Profit
Net Income / Loss	$-274.85M	$-62.51M	$-48.57M
Operating Income / Loss	$-185.67M	$-63.81M	$-50.22M
Cost of Revenue
Net Cash Flow	$-25.1M	$1.85M	$-30.82M
PE Ratio